Mediators of Inflammation

Immune Regulatory Cells in Inflammation, Infection, Tumor, Metabolism, and Other Diseases 2019


Publishing date
01 Jun 2019
Status
Published
Submission deadline
08 Feb 2019

Lead Editor

1CancerCare Manitoba, Winnipeg, Canada

2China-Japan Friendship Hospital, Beijing, China

3Memorial Sloan Kettering Cancer Center, New York, USA


Immune Regulatory Cells in Inflammation, Infection, Tumor, Metabolism, and Other Diseases 2019

Description

The immune system is the host defense against infection, inflammation, tumor, and other diseases. The regulatory arm of immune system, including regulatory immune cells, regulatory complement, and regulatory cytokines, plays important roles in controlling immune responses and shutting down inflammation. However, cancer and some pathogens may escape and/or limit immune responses by driving immune regulatory cells. The balance of regulatory arm and effector arm of immune system maintains immune homeostasis. The recent advance has greatly increased our understanding of immune regulatory cells in health and pathogenesis of inflammation, infection, tumor, and other diseases. Immune regulatory cells are a large group of cells, such as regulatory T cells, myeloid-derived suppressor cells, mesenchymal stromal/stem cells, regulatory neutrophils, regulatory eosinophils, and other immune cells with regulatory functions. One of the keys to control infection, inflammation, tumor, and other diseases is to improve the understanding of immune regulatory cells in these situations.

We invite authors to submit original research articles and literature reviews that seek to define the roles of immune regulatory cells in health and pathogenesis of infection, inflammation, tumor, and other diseases and that explore the potential treatment/target for diseases.

Potential topics include but are not limited to the following:

  • Identifying the development, roles, and/or mechanisms of immune regulatory cells or novel cells with immune regulatory functions, in health and pathogenesis of infection, inflammation, tumor, and other diseases
  • Identifying the cross-talk and mechanisms of immune regulatory cells with regulatory/memory/effector immune cells and mediators of inflammation
  • Clinical and preclinical evaluation of immune regulatory cells in the diagnosis and treatment of diseases
Mediators of Inflammation
 Journal metrics
See full report
Acceptance rate14%
Submission to final decision136 days
Acceptance to publication27 days
CiteScore7.700
Journal Citation Indicator0.570
Impact Factor4.6
 Submit Evaluate your manuscript with the free Manuscript Language Checker

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.